Akoya Biosciences, Inc.
NASDAQ:AKYA
2.49 (USD) • At close December 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|
Operating Activities: | |||||
Net Income
| -63.323 | -70.641 | -42.935 | -16.706 | -14.751 |
Depreciation & Amortization
| 8.89 | 7.149 | 4.792 | 3.815 | 3.055 |
Deferred Income Tax
| -0.051 | 0.035 | -0.155 | 0.007 | 0.156 |
Stock Based Compensation
| 10.437 | 7.43 | 4.039 | 0.477 | 0.153 |
Change In Working Capital
| -14.478 | 2.164 | -4.561 | 2.394 | -1.377 |
Accounts Receivables
| -7.265 | -0.285 | -2.974 | 6.697 | -3.373 |
Inventory
| -6.332 | -5.374 | -4.628 | -0.684 | -4.007 |
Accounts Payables
| 1.148 | 1.193 | 4.361 | -3.045 | -0.049 |
Other Working Capital
| -2.029 | 6.63 | -1.32 | -0.574 | 6.052 |
Other Non Cash Items
| 7.626 | 0.367 | 2.752 | 3.17 | -1.012 |
Operating Cash Flow
| -50.899 | -53.496 | -36.068 | -6.843 | -13.776 |
Investing Activities: | |||||
Investments In Property Plant And Equipment
| -3.653 | -7.36 | -5.094 | -3.295 | -2.869 |
Acquisitions Net
| 0 | 0.055 | 0 | 0.145 | 0 |
Purchases Of Investments
| 0 | -40.774 | 0 | -0.145 | -10 |
Sales Maturities Of Investments
| 7 | 34 | 0 | 10.168 | 0 |
Other Investing Activites
| 0 | -6.719 | 0 | -0.145 | -0.023 |
Investing Cash Flow
| 3.347 | -14.079 | -5.094 | 6.728 | -12.892 |
Financing Activities: | |||||
Debt Repayment
| 10.574 | 30.629 | -0.322 | 9.785 | 4.959 |
Common Stock Issued
| 47.967 | 0.447 | 138.553 | 0.122 | 24.828 |
Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 |
Dividends Paid
| 0 | 0 | -1.435 | 0 | 0 |
Other Financing Activities
| -1.697 | -1.903 | 0.239 | -4.299 | 48.426 |
Financing Cash Flow
| 56.844 | 28.726 | 137.035 | 5.486 | 28.561 |
Other Information: | |||||
Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 |
Net Change In Cash
| 9.292 | -38.849 | 95.873 | 5.371 | 1.893 |
Cash At End Of Period
| 83.824 | 74.532 | 113.381 | 17.508 | 12.137 |